- Home
- BOH vs HCM Comparison
BOH vs HCM Comparison
Compare BOH & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOH
- HCM
- Stock Information
- Founded
- BOH 1897
- HCM 2000
- Country
- BOH United States
- HCM Hong Kong
- Employees
- BOH N/A
- HCM N/A
- Industry
- BOH Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- BOH Finance
- HCM Health Care
- Exchange
- BOH Nasdaq
- HCM Nasdaq
- Market Cap
- BOH 2.8B
- HCM 2.5B
- IPO Year
- BOH N/A
- HCM N/A
- Fundamental
- Price
- BOH $65.11
- HCM $14.84
- Analyst Decision
- BOH Hold
- HCM Hold
- Analyst Count
- BOH 6
- HCM 1
- Target Price
- BOH $71.67
- HCM $19.00
- AVG Volume (30 Days)
- BOH 278.0K
- HCM 90.6K
- Earning Date
- BOH 07-21-2025
- HCM 07-30-2025
- Dividend Yield
- BOH 4.30%
- HCM N/A
- EPS Growth
- BOH N/A
- HCM N/A
- EPS
- BOH 3.56
- HCM 0.04
- Revenue
- BOH $640,351,000.00
- HCM $630,201,000.00
- Revenue This Year
- BOH $15.73
- HCM $14.86
- Revenue Next Year
- BOH $7.97
- HCM $19.54
- P/E Ratio
- BOH $18.28
- HCM $66.84
- Revenue Growth
- BOH N/A
- HCM N/A
- 52 Week Low
- BOH $55.43
- HCM $11.51
- 52 Week High
- BOH $82.70
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- BOH 41.53
- HCM 46.89
- Support Level
- BOH $64.30
- HCM $15.02
- Resistance Level
- BOH $66.40
- HCM $18.00
- Average True Range (ATR)
- BOH 1.22
- HCM 0.42
- MACD
- BOH -0.23
- HCM -0.04
- Stochastic Oscillator
- BOH 17.20
- HCM 31.45
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.